GCG and type 2 diabetes mellitus: The metabolic problem is that glucagon appears to elicit a persistent gluconeogenic effect in T2D which was quite clearly shown by the use of glucagon antagonists – which also increased liver fat and circulating fat as may be expected (35, 39).